Why 2026 may be a strong year for biotech stocks

Core Insights - Biotech stocks have experienced a significant rally over the past six months, with the XBI index, a key benchmark for small and mid-cap biotech companies, achieving one of its strongest performance periods on record [1] Industry Performance - The XBI index has shown remarkable strength, indicating a positive trend in the biotech sector, particularly for smaller and mid-sized companies [1]